Investors
The ReSyn team is seeking investors with a shared vision and passion, and valuable networks capable of growing the enterprise.
ReSyn Biosciences currently offers a portfolio of innovative magnetic microparticle products, MagReSyn®, designed to specifically address the requirements of bioseparation, mass spectrometry and proteomics sample preparation. The products aim to address key limitations in R&D workflows, including reproducibility and low throughput, by developing automated workflows, and enabling clinical mass spectrometry applications. We follow and active partnering and co-development programme, where new opportunities may be enabled with the proprietary technology platform.
Please contact Justin Jordaan to find out more about potential investment.
Why Invest?
TEAM
The company was founded by the original inventive team, ensuring transfer of knowledge and the relevant skills for new product development. The team have experience and knowledge in life-sciences research and development, including proteomics, biocatalysis, protein chemistry, and bioseparation.
INTELLECTUAL PROPERTY
ReSyn Biosciences has an exclusive license (and right to assignment) for intellectual IP to the proprietary polymer microparticle technology developed and patented at the CSIR (WO2009057049; IN267234; US9574054; ES2595104; EP2205662; DK2205662; CN101874061; CA2703478; JP五四四二六二四).
COLLABORATION NETWORK
ReSyn Bio is involved in automating complex mass spectrometry workflows in collaboration with leading proteomics laboratories and thought leading scientists, and enabling high-throughput sample preparation platforms towards clinical applications in proteomics. Please like and follow our social media pages, twitter and LinkedIn to hear about the most recent developments at ReSyn Biosciences.
IMPACT
Our products are being used to identify new mechanisms of disease, with the biggest impact in cancer research. Please review the method library to see the most recent citations using our research reagents.
PIPELINE
ReSyn Bio has a pipeline of new products and diagnostic technologies in development, including OEM opportunities currently under evaluation.
INTELLECTUAL PROPERTY
ReSyn Biosciences has an exclusive license to the proprietary polymer microparticle technology developed and patented at the CSIR (WO2009057049; IN267234; US9574054; ES2595104; EP2205662; DK2205662; CN101874061; CA2703478; JP五四四二六二四). ReSyn Biosciences (Pty) Ltd is a biotechnology company founded by the technology inventors.
TERMS AND CONDITIONS
Products supplied by ReSyn Biosciences (Pty) Ltd are for research purposes only. ReSyn products are not to be used for diagnostic, therapeutic or commercial means any use resulting in monetary gain, including, but not limited to, incorporation in a kit, repackaging and re-formulation. Please enquire about sub-licenses for commercial use.
